Mathew Sorensen, MD, MS, FACS, Associate Professor of Urology, University of Washington School of Medicine, Seattle, Washington, examines the management of asymptomatic small kidney stones, particularly when discovered incidentally during imaging or when patients undergo surgery for a primary stone. There is a noted clinical debate on whether these additional, often small, stones warrant treatment.
In this 14-minute presentation, Dr. Sorensen highlights that residual fragments frequently persist after lithotripsy, posing potential risks, including emergency visits or further surgeries. A multicenter randomized clinical trial, published in the New England Journal of Medicine, sought to clarify this issue. The results show a significantly lower relapse rate (16%) in the treatment group compared to the control group (63%)suggesting a substantial benefit in reducing future stone-related events. The study underscores the evolving approach in urology towards more proactive treatment of small stones, facilitated by less invasive technologies.
In this 14-minute presentation, Dr. Sorensen highlights that residual fragments frequently persist after lithotripsy, posing potential risks, including emergency visits or further surgeries. A multicenter randomized clinical trial, published in the New England Journal of Medicine, sought to clarify this issue. The results show a significantly lower relapse rate (16%) in the treatment group compared to the control group (63%)suggesting a substantial benefit in reducing future stone-related events. The study underscores the evolving approach in urology towards more proactive treatment of small stones, facilitated by less invasive technologies.
- Category
- Urology

Be the first to comment